Opiates Flashcards
opium origin
- somniferum: somni = sleep
- poppy plant, papaver
- morphine, morpheus: god of dreams
- dreamy euphoria
- pain relief
natural opiates
- codeine
- morphine
semi-synthetic opiates
- heroin
- slightly altered in lab
synthetic opiates
- fentanyl
- very powerful: used for anaesthesia
- “china white”: illegal version
history of opiates and opium
- ancient times: joy plant
- sumarians and assyrians
- ancient egypt, greece, rome (medical use)
- islam: arab traders (substitute for alcohol)
- india and china: from arab traders (can’t tolerate alcohol, introduced smoking opiates)
- europe: war, trade, exploration
drug use in the 1800’s
- widespread through europe and usa
- few restrictions on sale and supply
- no prescription needed
- cure many aliments: panacea
- high degree of addiction
- new methods of administration: smoking (chinese), injections (civil war, soldiers disease)
- opium wars (britain vs. china)
- opium did not produce aggression or violence: no urge to ban
- kept the poor quiescent
- late 1800’s: heroin = 2x potent in brain
- Harrison Narcotics act 1914
- controlled drugs act 1970
modern medical use
- pain relief / analgesia: main medical use
- diarrhea: loperamide (oral rehydration therapy is more common)
- cough suppression: codeine linctus (suppresses coughing center in the brain: dry cough)
abuse of prescription opiates
- oxytocin
- when doc stops prescribing, already addicted patients turn to illegal opioids
Morphine standart
- standard by which others are measured
- analgesia value of 1
- more potent: heroin (2), oxycodone (1.5)
- equipotent: hydrocodone
- less potent: codeine (10x weaker)
- fentanyl: 100x more potent
pain and pain relief
- important warning / survival mechanism
- stimilus (nociceptors) > pain pathways > spinal cord > perceived in the brain (cortex)
brains response to pain
- release endorphins: endogenous opioid peptides (small protein)
- natural pain-killers
- analgesia and well-being
endorphins
- natural pain-killers
- inhibitory neurotransmitters
- bind to post-synaptic opiate receptos via signal transdoction pathway
- open potassium channels, K+ exit the cell
= hyperpolarization (very negative charge inside the cell, very unlikely to reach threshold)
= post-synaptic inhibition
= inhibit pain signal
= inhibit the perception of pain in the cortex
opiates and endorphines
- morphine and other opiates: structurally similar to endorphins (mimic natural endorphins)
- are agonists at the endorphin (opiate) receptor
- opiates inhibit pain transmission
- CNS depressants
- analgesia and sleepiness
opiate receptors
- 3 main receptors: µ, κ, δ
- morphine and heroine: µ receptor
- µ- receptor associated with euphoria
- κ-receptor: dysphoric effects, thought to balance out euphoric effects of endorphins in vivo (otherwise one would become addicted to pain)
- κ-receptors: new target for pain-relief therapies, that are not addictive
pharmacokinetics: absorption
- oral
- inhalation
- intranasal: not so much
- subcutaneous injection:
- intramuscular injection: slower than IV, but constant release, painful
- intravenous: veins get damaged over time (collapsed veins)
Addicts: progression in injection
- inject right under the skin: subcutaneous
- intramuscular
- IV: problem with sharing needles
- life expectancy for IV addict: 1 year
chasing the dragon
don’t want to heat heroin up too much: slang term for right heating
distribution
- body organs, including brain
- morphine poorly penetrated BBB
- heroin (diacetylmorphine): more lipidic = penetrates BBB more easily, once in brain it is converted to morphine
metabolism and excretion
- liver metabolism
- urine excretion
- 90% excreted within 1 day
- traces detectable for 2-4 days
- more or less 4 h action and 8 h to be removed
opiates addictive
- euphoria, rush, well-being, dopamine release: limbic system
- GABA: inhibitory effect on dopamine release in parts of the mesolumbic system (opening of gaba receptors: Cl- flows in: hyperpolarization)
- opiates inhibit GABA release
- inhibit an inhibitory NT: enhance dopamine release
- morphine prevents release of GABA, therefore GABA can’t prevent dopamine release anymore
- µ- receptor associated with euphoria
- addictive effect because of euphoria from dopamine release
acute effects: opiates
- euphoria (rush)
- drowsiness, heavy limbs, vivid dream-like experiences
- body warmth
- intense introversion and impaired social interaction
- choice of drug use can depend on personality type
- CNS depressant
- respiratory depression (less than 12 bpm, drug not administered in clinical setting)
- cognitive impairment
- cough suppression
- nausea, vomiting: built tolerance to this
- constipation: more water absorption, no tolerance to this
- pin-point pupils: very small pupils
toxicity
- more or less 4000 † per year
- CNS depressant: severe respiratory depression: less than 12 bpm
- coma > death
- clinical manifestations: coma, respiratory depression, pinpoint pupils (toxic triad for opioid use)
chronic effects: opiates
- abusers: short life span (overdose, infections)
- 100x more likely to die
- infection and disease: HIV (25% of IV users): virus attacks white blood cells
- drug overdose: narrow therapeutic index, mix of CNS depressants
- criminal activity
- opiate abuse during pregnancy: developmental delays
- higher risk for stroke, embolism: dirt that clogs the veins
- hepatitis: inflammation of liver: spread through needles
- dead skin: due to loss of blood vessels
- neumonias: due to cough suppression
- respiratory infection
- endocarditis: heart infections
opioid interactions
- synergism with other CNS depressants
- anxiolytics (benzodiazepines), alcohol
- potentiation of CNS depression